L.B. Foster Company (FSTR) Sidoti Small-Cap Virtual Conference summary

Company transformation and strategic focus

• Underwent significant transformation since 2021, divesting lower-margin businesses and acquiring higher-margin rail technologies and precast concrete companies.

• Now operates in two main segments: Rail Technology Services and Infrastructure Solutions, with rail comprising 60% of sales and a focus on technology-driven solutions.

• Growth driven by organic initiatives and targeted acquisitions, especially in precast and technology platforms.

• Heavy lifting of transformation is complete, with focus now on sustainable growth and profitability.

• Positioned to benefit from the infrastructure investment super cycle, with government funding and safety initiatives expected to drive demand.

Financial performance and guidance

• 2024 net sales reached $530.8M, with a gross margin of 22.2% and adjusted EBITDA of $33.6M, reflecting improved profitability.

• Achieved strong cash generation and profitability expansion in 2024, with net debt reduced to 1.2x and a reduction of $8.2M.

• 2025 guidance projects net sales of $540M–$580M, adjusted EBITDA of $42M–$48M, and free cash flow of $20M–$30M, with capex at ~2% of sales.

• A $40M share repurchase program was authorized through February 2028, supporting shareholder value.

• Attractive valuation with 10x 2024 EBITDA and a targeted 2025 free cash flow yield of 9%–14% at current stock prices.

Growth drivers and market opportunities

• Precast growth fueled by demographic shifts to the South/Southeast and new facilities in Florida and Tennessee.

• Global Friction Management and Precast Concrete Products showed strong sales and margin expansion, with only 5% of the rail market currently served.

• Substantial pent-up demand from federal infrastructure and rail safety grants, with much funding yet to be spent.

• Renewed activity in domestic energy, especially oil and gas, with recent hiring and facility expansion.

• Backlog and book-to-bill ratios remained healthy, with a consolidated Q4 2024 book-to-bill ratio of 0.95:1.00.